BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/10/2026 10:08:05 AM | Browse: 26 | Download: 1
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Farah Khaznadar, Kristina Bojanic, Omar Khaznadar, Ana Jurić, Marija Hefer, Kristina Kralik, Ana Petrović, Ana Hrženjak, Ana Lončar, Justinija Steiner, Martina Smolić and Robert Smolić |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| European Union-Next Generation EU through programme funding of the University of Osijek (UNIOS)-Institutional Project |
581-UNIOS-46 |
|
| Corresponding Author |
Martina Smolić, Full Professor, Research Dean, Department of Translational Medicine, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, Crkvena 21, Osijek 31000, Croatia. msmolic@fdmz.hr |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Type 2 diabetes mellitus; Sodium-glucose cotransporter 2 inhibitors; Two-dimensional shear wave elastography; Ultrasound-guided attenuation parameter; Sterol regulatory element-binding protein 1c; Peroxisome proliferator-activated receptor gamma; Peroxisome proliferator-activated receptor alpha; Microsomal triglyceride transfer protein |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease lacks effective pharmacologic therapies and robust biomarkers for monitoring treatment response. In this prospective observational study, sodium-glucose cotransporter 2 inhibitors therapy was associated with modulation of selected circulating lipogenesis biomarkers and a modest reduction in liver stiffness of uncertain clinical relevance, whereas steatosis measures remained largely unchanged over 6 months. |
| Citation |
Khaznadar F, Bojanic K, Khaznadar O, Jurić A, Hefer M, Kralik K, Petrović A, Hrženjak A, Lončar A, Steiner J, Smolić M, Smolić R. Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes. World J Hepatol 2026; In press
|
| PDF |
125505-in-press.pdf
|
 |
Received |
|
2026-07-09 06:12 |
|
Peer-Review Started |
|
2026-07-09 06:13 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-07-23 07:56 |
|
Revised |
|
2026-08-03 18:31 |
|
Publication Fee Transferred |
|
2026-08-21 09:10 |
|
Second Decision by Editor |
|
2026-09-10 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-09-10 10:08 |
|
Articles in Press |
|
2026-09-10 10:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
